As of 2025-03-22, the Relative Valuation of NGM Biopharmaceuticals Inc (NGM) is (23.37) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.54 USD, the upside of NGM Biopharmaceuticals Inc based on Relative Valuation is -1617.6%.
The range of the Relative Valuation is (19.04) - (30.43) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 7.7x - 17.8x | 11.0x |
| Forward P/E multiples | 11.2x - 20.9x | 16.4x |
| Fair Price | (19.04) - (30.43) | (23.37) |
| Upside | -1336.3% - -2076.3% | -1617.6% |
| Date | P/E |